{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:02:04Z","timestamp":1772751724480,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.mehy.2005.12.011","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T14:54:49Z","timestamp":1138373689000},"page":"1182-1187","source":"Crossref","is-referenced-by-count":14,"title":["Immunoplacental therapy, a potential multi-epitope cancer vaccine"],"prefix":"10.1016","volume":"66","author":[{"given":"Amir","family":"Harandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2005.12.011_bib1","series-title":"Immunology of pregnancy and cancer","author":"Govallo","year":"1993"},{"key":"10.1016\/j.mehy.2005.12.011_bib2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/bjc.1978.41","article-title":"A vaccine containing autogenous term placenta and an immunopoteniator to reduce the incidence of autochthonous cancer","volume":"37","author":"Vitou","year":"1978","journal-title":"Br J Cancer"},{"key":"10.1016\/j.mehy.2005.12.011_bib3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ni1037","article-title":"Regulatory T cells mediate maternal tolerance to the fetus","volume":"5","author":"Aluvihare","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2005.12.011_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000087834","article-title":"Signal transduction in trophoblast invasion","volume":"88","author":"Fitzgerald","year":"2005","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.mehy.2005.12.011_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00665772","article-title":"High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: A preventive mechanism of malignant tumor cells against complement attack?","volume":"32","author":"Hofman","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.mehy.2005.12.011_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000063690","article-title":"Vasculogenesis, angiogenesis and the molecular organization of endothelial junctions in the early human placenta","volume":"39","author":"Leach","year":"2002","journal-title":"J Vasc Res"},{"key":"10.1016\/j.mehy.2005.12.011_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"7","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2005.12.011_bib8","first-page":"3560","article-title":"Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis","volume":"6","author":"Okada","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mehy.2005.12.011_bib9","first-page":"25","article-title":"Apoptosis and human placenta: Expression of proteins belonging to different apoptotic pathways during pregnancy","volume":"24","author":"DeFalco","year":"2005","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.mehy.2005.12.011_bib10","first-page":"97","article-title":"Melanoma vaccines: What we know so far","volume":"97","author":"Bystryn","year":"2005","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.mehy.2005.12.011_bib11","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1365-2133.2004.06260.x","article-title":"Melanoma or not? Cancer testis antigens may help","volume":"151","author":"Luftl","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mehy.2005.12.011_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1034\/j.1600-065X.2002.18803.x","article-title":"Cancer\/testis antigens: An expanding family of targets for cancer immunotherapy","volume":"188","author":"Scanlan","year":"2002","journal-title":"Immunol Rev"},{"key":"10.1016\/j.mehy.2005.12.011_bib13","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.1158\/1078-0432.CCR-04-1177","article-title":"Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice","volume":"10","author":"Nakatsura","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mehy.2005.12.011_bib14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.vaccine.2004.08.007","article-title":"Lack of toxicity of therapy-induced T cell responses against the universal tumor antigen survivin","volume":"23","author":"Otto","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.mehy.2005.12.011_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1479-5876-2-19","article-title":"Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer","volume":"2","author":"Tsuruma","year":"2004","journal-title":"J Transl Med"},{"key":"10.1016\/j.mehy.2005.12.011_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00704377","article-title":"The ultrastructural immunohistochemistry of oncofetal antigens in large bowel carcinomas","volume":"405","author":"Haynes","year":"1985","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.mehy.2005.12.011_bib17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/1097-0142(19810315)47:6<1241::AID-CNCR2820470602>3.0.CO;2-Y","article-title":"Tumor-associated antigens in polyps and carcinoma of the human large bowel","volume":"47","author":"Skinner","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.mehy.2005.12.011_bib18","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.1016\/S0021-9258(17)37110-7","article-title":"Isolation of a cDNA encoding 5T4 oncofetal trophoblast glycoprotein, An antigen associated with metastasis contains leucine-rich repeats","volume":"25","author":"Myers","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2005.12.011_bib19","first-page":"211","article-title":"Markers for ovarian cancer: Regan isoenzyme and other glycoproteins","volume":"2","author":"Fishman","year":"1975","journal-title":"Semin Oncol"},{"key":"10.1016\/j.mehy.2005.12.011_bib20","first-page":"10","article-title":"SCP-1 cancer\/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer","volume":"4","author":"Tammela","year":"2004","journal-title":"Cancer Immun"},{"key":"10.1016\/j.mehy.2005.12.011_bib21","first-page":"557","article-title":"Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein","volume":"142","author":"Garin-Chesa","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2005.12.011_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/172460088900400203","article-title":"Distribution of CA125 in placental tissues","volume":"4","author":"Fuith","year":"1989","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.mehy.2005.12.011_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/cbr.2000.15.495","article-title":"Vaccination with a mixed vaccine of autogenous and allogeneic breast cancer cells and tumor associated antigens CA15-3, CEA and CA125\u2013results in immune and clinical responses in breast cancer patients","volume":"15","author":"Jiang","year":"2000","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.mehy.2005.12.011_bib24","first-page":"363","article-title":"Immunosuppressive activity of lymphocyte mitogenesis by breast cancer-associated p43","volume":"43","author":"Reinerova","year":"1996","journal-title":"Neoplasma"},{"key":"10.1016\/j.mehy.2005.12.011_bib25","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/clinchem\/34.10.1995","article-title":"Multicenter evaluation of human placental alkaline phosphatase as a possible tumor-associated antigen in serum","volume":"34","author":"DeBroe","year":"1988","journal-title":"Clin Chem"},{"key":"10.1016\/j.mehy.2005.12.011_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/PL00012077","article-title":"Analysis of MAGE-3 derived synthetic peptide as a human lung cancer antigen recognized by cytotoxic T lymphocytes","volume":"6","author":"Eifuku","year":"2001","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.mehy.2005.12.011_bib27","first-page":"51","article-title":"Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels","volume":"7","author":"Slodkowska","year":"1998","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.mehy.2005.12.011_bib28","first-page":"225","article-title":"Human decidual cells can express the Hodgkin\u2019s cell-associated antigen Ki-1 (CD30) in spontaneous abortions during the first trimester of gestation","volume":"28","author":"Papadopoulos","year":"2001","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.mehy.2005.12.011_bib29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/(SICI)1096-9896(200004)190:5<613::AID-PATH559>3.0.CO;2-0","article-title":"Expression of the CD30 antigen in non-lymphoid tissues and cells","volume":"190","author":"Durkop","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.mehy.2005.12.011_bib30","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.onc.1203426","article-title":"Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer","volume":"19","author":"Gu","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.mehy.2005.12.011_bib31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1210\/jc.85.1.317","article-title":"Prostate-specific antigen synthesis and secretion by human placenta: A physiological kallikrein source during pregnancy","volume":"85","author":"Malatesta","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2005.12.011_bib32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1055\/s-2004-818510","article-title":"Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens","volume":"35","author":"Prikler","year":"2004","journal-title":"Aktuelle Urol"},{"key":"10.1016\/j.mehy.2005.12.011_bib33","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1464-410x.2000.00939.x","article-title":"A new highly specific monoclonal antibody against placental alkaline phosphatase: A potential marker for the early detection of testis tumor","volume":"86","author":"Nouri","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.mehy.2005.12.011_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ijc.1584","article-title":"Characterization of XAGE-1b, a short major transcript of cancer\/testis-associated gene XAGE-1, induced in melanoma metastasis","volume":"97","author":"Zendman","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.mehy.2005.12.011_bib35","first-page":"13","article-title":"SSX antigens as tumor vaccine targets in human sarcoma","volume":"3","author":"Ayyoub","year":"2003","journal-title":"Cancer Immun"},{"key":"10.1016\/j.mehy.2005.12.011_bib36","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.bjc.6602460","article-title":"Identification and analysis of tumor-associated antigens in hepatocellular carcinoma","volume":"92","author":"Shi","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.mehy.2005.12.011_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/gyno.1998.4988","article-title":"Immune recognition of endometrial tumor antigens induced by multiparity","volume":"70","author":"Katsanis","year":"1998","journal-title":"Gynecol Oncol B"},{"key":"10.1016\/j.mehy.2005.12.011_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/molehr\/gah001","article-title":"X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis","volume":"10","author":"Straszewski-Chavez","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.mehy.2005.12.011_bib39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.coph.2004.03.008","article-title":"The Fas signaling pathway and its role in the pathogenesis of cancer","volume":"4","author":"Houston","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.mehy.2005.12.011_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jri.2005.01.007","article-title":"Fas ligand expression by maternal decidual cells is negatively correlated with the abundance of leukocytes present at the maternal-fetal interface","volume":"65","author":"Qiu","year":"2005","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.mehy.2005.12.011_bib41","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1349-7006.2004.tb02181.x","article-title":"TRAIL and its receptors as targets for cancer therapy","volume":"95","author":"Yagita","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.mehy.2005.12.011_bib42","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.162.10.6053","article-title":"TRAIL (Apo-2L) and TRAIL receptors in human placentas: Implications for immune privilege","volume":"162","author":"Phillips","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2005.12.011_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2005.12.011_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2005.12.011_bib45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jlb.65.5.535","article-title":"To die or not to die \u2013 the quest of the TRAIL receptors","volume":"65","author":"Degli-Esposti","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.mehy.2005.12.011_bib46","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.277.5327.818","article-title":"Control of TRAIL \u2013 induced apoptosis by a family of signaling and decoy receptors","volume":"277","author":"Sheridan","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.mehy.2005.12.011_bib47","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/13543784.10.8.1521","article-title":"Concepts in the use of TRAIL\/Apo2L: An emerging biotherapy for myeloma and other neoplasias","volume":"10","author":"Mitsiades","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.mehy.2005.12.011_bib48","first-page":"1731","article-title":"An HLA-A24-restricted cytotoxic T-lymphocyte epitope of a tumor-associated protein, survivin","volume":"8","author":"Hirohashi","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mehy.2005.12.011_bib49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/0008-5472.553.65.2","article-title":"A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication","volume":"65","author":"Xiang","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2005.12.011_bib50","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.vaccine.2004.08.007","article-title":"Lack of toxicity of therapy-induced T-cell responses against the universal tumor antigen survivin","volume":"23","author":"Otto","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.mehy.2005.12.011_bib51","first-page":"1634","article-title":"Anti-apoptosis protein, survivin-2B-derived peptide vaccine therapy","volume":"31","author":"Tsuruma","year":"2004","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.mehy.2005.12.011_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1479-5876-2-19","article-title":"Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer","volume":"2","author":"Tsuruma","year":"2004","journal-title":"J Transl Med"},{"key":"10.1016\/j.mehy.2005.12.011_bib53","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ejim.2003.10.003","article-title":"Angiogenesis in human cancer: Implications in cancer therapy","volume":"14","author":"Bamias","year":"2003","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.mehy.2005.12.011_bib54","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2005.10.017","article-title":"Bevacizumab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer","volume":"23","author":"Hurwitz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mehy.2005.12.011_bib55","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000063690","article-title":"Vasculogenesis, angiogenesis and the molecular organization of endothelial junctions in the early human placenta","volume":"39","author":"Leach","year":"2002","journal-title":"J Vasc Res"},{"key":"10.1016\/j.mehy.2005.12.011_bib56","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/mrd.10331","article-title":"Expression of angiogenesis \u2013 and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients","volume":"66","author":"Choi","year":"2003","journal-title":"Mol Reprod Dev"},{"key":"10.1016\/j.mehy.2005.12.011_bib57","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0161-5890(99)00115-7","article-title":"Complement resistance of tumor cells: Basal and induced mechanisms","volume":"36","author":"Jurianz","year":"1999","journal-title":"Mol Immunol"},{"key":"10.1016\/j.mehy.2005.12.011_bib58","first-page":"959","article-title":"Immunization against tumor cell surface complement-regulatory proteins","volume":"2","author":"Durrant","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.mehy.2005.12.011_bib59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molimm.2005.06.017","article-title":"The complement system in the pathophysiology of pregnancy","volume":"43","author":"Girardi","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.mehy.2005.12.011_bib60","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1515\/JPM.2005.052","article-title":"Unexplained intrauterine fetal death is accompanied by activation of complement","volume":"33","author":"Richani","year":"2005","journal-title":"J Perinat Med"},{"key":"10.1016\/j.mehy.2005.12.011_bib61","first-page":"145","article-title":"Effect of abnormal apoptosis in human decidual tissue during early gestation on pregnancy","volume":"22","author":"Ding","year":"2002","journal-title":"Di Yi Jun Yi Da Xue Xue Bao"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987705006663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987705006663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T09:54:07Z","timestamp":1683366847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987705006663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0306987705006663"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2005.12.011","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}